Brief: Lipidor: Last Patient Out In Calcipotriol/AKVANO Phase III Study Targeting Psoriasis
07/11/2019 10:12
Nov 7 (Reuters) - Lipidor AB LIPI.ST :
* LIPIDOR ANNOUNCES LAST PATIENT OUT IN CALCIPOTRIOL/AKVANO
SPRAY
(AKP01) PHASE III STUDY TARGETING PSORIASIS
* RESULTS FROM STUDY ARE EXPECTED TO BE PRESENTED IN
DECEMBER 2019
Source text for Eikon: ID:nWkr1Sn6nT
Further company coverage: LIPI.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))